Table I.
Time after injury | ||||||||
---|---|---|---|---|---|---|---|---|
Week 1 | Week 2 | Week 3 | Week 4 | |||||
Neointimal cells | ||||||||
u-PAR+/+ | 11 ± 2 | 8 ± 2 | 5 ± 2 | 0.5 ± 0.3 | ||||
u-PAR−/− | 8 ± 2 | 15 ± 3 | 4 ± 1 | 0.3 ± 0.3 | ||||
Medial cells | ||||||||
u-PAR+/+ | 29 ± 4 | 15 ± 4 | 12 ± 3 | 0.8 ± 0.5 | ||||
u-PAR−/− | 21 ± 4 | 37 ± 4* | 23 ± 10 | 0.4 ± 0.3 |
Proliferation of medial and neointimal cells was quantified by counting the number of 5′-bromo-2′-deoxyuridine–positive nuclei on five equally spaced sections per artery across the injured segment, and were averaged per artery. The values represent the mean ± SEM of these averages in groups containing between 8 and 14 arteries. u-PAR +/+, wild type; u-PAR −/−, u-PAR deficient.
P < 0.05 vs. wild type by analysis of variance.